Thrivent Financial for Lutherans Acquires 8,368 Shares of Cardinal Health, Inc. $CAH

Thrivent Financial for Lutherans increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 60.1% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 22,289 shares of the company’s stock after buying an additional 8,368 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Cardinal Health were worth $4,586,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Allworth Financial LP increased its holdings in Cardinal Health by 16.3% in the 4th quarter. Allworth Financial LP now owns 5,038 shares of the company’s stock worth $1,035,000 after buying an additional 706 shares in the last quarter. Moneco Advisors LLC bought a new stake in Cardinal Health in the 4th quarter worth about $219,000. Ameritas Advisory Services LLC increased its holdings in Cardinal Health by 463.8% in the 4th quarter. Ameritas Advisory Services LLC now owns 1,043 shares of the company’s stock worth $214,000 after buying an additional 858 shares in the last quarter. Community Bank N.A. bought a new stake in Cardinal Health in the 4th quarter worth about $45,000. Finally, World Investment Advisors increased its holdings in Cardinal Health by 42.2% in the 4th quarter. World Investment Advisors now owns 7,412 shares of the company’s stock worth $1,523,000 after buying an additional 2,200 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Down 0.1%

Cardinal Health stock opened at $200.42 on Friday. The business has a 50-day simple moving average of $205.21 and a two-hundred day simple moving average of $208.69. The company has a market cap of $46.94 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the firm earned $2.35 EPS. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.19%.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 2nd. Mizuho boosted their price target on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research note on Friday, February 6th. William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Evercore cut their price target on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Finally, Robert W. Baird set a $248.00 price target on Cardinal Health in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.